Piperazine

Piperazine

SCHEMBL28845954

C1CNCCN1.CN(C)C(=O)CN1CCNCC1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.54
ALDH1A1 P00352 1/20 0.50
CHRM5 P08912 2/20 0.49
CHRM3 P20309 2/20 0.49
DRD2 P14416 1/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CXCR4 P61073 1/20 0.34
BIRC2 Q13490 1/20 0.34
DRD4 P21917 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5863 0.98 SIGMAR1 (0.56) SIGMAR1ALDH1A1CHRM5CHRM3DRD2
Hydrochloric Acid SCHEMBL963162 0.96 ALDH1A1 (0.54) SIGMAR1ALDH1A1CHRM5CHRM3DRD2
Hydrochloric Acid SCHEMBL17271878 0.96 ALDH1A1 (0.54) SIGMAR1ALDH1A1CHRM5CHRM3DRD2
SCHEMBL2011012 0.91 SIGMAR1 (0.64) SIGMAR1ALDH1A1CHRM5CHRM3DRD2
Hydrochloric Acid SCHEMBL2009563 0.89 SIGMAR1 (0.62) SIGMAR1ALDH1A1CHRM5CHRM3DRD2
SCHEMBL8393969 0.86 SIGMAR1 (0.53) SIGMAR1ALDH1A1CHRM5CHRM3MEN1
Trifluoroacetic Acid SCHEMBL21816637 0.86 SIGMAR1 (0.47) SIGMAR1ALDH1A1CHRM5CHRM3DRD2
SCHEMBL9470969 0.82 SIGMAR1 (0.53) SIGMAR1ALDH1A1CHRM5CHRM3MEN1
SCHEMBL665674 0.81 SIGMAR1 (0.61) SIGMAR1ALDH1A1CHRM5CHRM3MEN1
SCHEMBL2010851 0.81 CHRM5 (0.54) SIGMAR1ALDH1A1CHRM5CHRM3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106928200-A For the pyrrolotriazine derivatives for the treatment of cancer 湖南福沃药业有限公司 2017-07-07 CN disclosed